IBM Research Blitz Falls Flat Despite $1 Billion Government Grant
IBM's research blitz has failed to lift its stock in recent weeks, despite announcing several high-profile projects. The company has secured $1 billion in federal support for its quantum wafer research and development, but investors remain skeptical about its near-term earnings power.
The CHIPS and Science Act funding agreement between IBM's chip unit Anderon and the US Department of Commerce was seen as a key event, but it failed to move the stock. The subsidy is meant to advance quantum wafer research and development on American soil, with early test wafers already moving through equipment.
IBM's legacy infrastructure business continues to cool, with a 7 percent slide in second-quarter revenue and a 42 percent collapse in Z mainframe sales. The company hopes to offset this shortfall with growth from newer segments, but investors remain cautious about its ability to do so.